Publication | Open Access

Padeliporfin vascular-targeted photodynamic therapy versus active surveillance in men with low-risk prostate cancer (CLIN1001 PCM301): an open-label, phase 3, randomised controlled trial

UrologyClin1001 Pcm301Photodynamic TherapyMedicineLow-risk Prostate CancerPharmacotherapyProstatic DiseaseOncologyRadiation OncologyPhase 3Health Sciences